Priming for Immunologic Memory in Adults by Meningococcal Group C Conjugate Vaccination

Autor: Vu, David M., de Boer, Alberdina W., Danzig, Lisa, Santos, George, Canty, Bridget, Flores, Betty M., Granoff, Dan M.
Zdroj: Clinical and Vaccine Immunology (formerly CDLI); June 2006, Vol. 13 Issue: 6 p605-610, 6p
Abstrakt: ABSTRACTMeningococcal group C polysaccharide-protein conjugate vaccines (MCV) prime infants and children for memory anticapsular responses upon subsequent exposure to unconjugated polysaccharide. The objective of this study was to determine whether MCV primes vaccine-nai¨ve adults and adults previously vaccinated with meningococcal polysaccharide vaccine (MPSV) for memory antibody responses. Meningococcal vaccine-nai¨ve adults were randomized to receive either MCV (MCV/nai¨ve group) (n= 35) or pneumococcal conjugate vaccine (PCV) (PCV/nai¨ve group) (n= 34). Participants with a history of receiving MPSV were given MCV (MCV/MPSV group) (n= 26). All subjects were challenged 10 months later with one-fifth of the usual dose of MPSV (10 µg of each polysaccharide). Sera were obtained before the conjugate vaccination and before and 7 days after the MPSV challenge and assayed for immunoglobulin G (IgG) anticapsular antibody concentrations and bactericidal titers. The MCV/nai¨ve group had 7- to 10-fold-higher serum IgG and bactericidal responses after the MPSV challenge than the PCV/nai¨ve group (P< 0.001). The increases (n-fold) in anticapsular antibody concentrations in the MCV/nai¨ve group were greatest in subjects with antibody concentrations of =2 µg/ml before the challenge (geometric mean increase [n-fold] of 8.3 versus 1.1 in subjects with concentrations of >2 µg/ml before the challenge; P< 0.0001). Only 3 of 11 MCV-vaccinated subjects who had received MPSV before enrollment and who had antibody concentrations of =2 µg/ml before the polysaccharide challenge showed more-than-twofold increases in anticapsular antibody concentration or bactericidal titer after the challenge. MCV vaccination of meningococcal vaccine-nai¨ve adults primes for robust memory antibody responses. There was no evidence of induction of memory by MCV in adults previously vaccinated with MPSV.
Databáze: Supplemental Index